The EVP, Prod. Dev. & Cust. Supp of Heska Corp (NASDAQ: HSKA) is Selling SharesBy Carrie Williams
Following Nancy Wisnewski’s last HSKA Sell transaction on February 27, 2017, the stock climbed by 17.4%. In addition to Nancy Wisnewski, 14 other HSKA executives reported Sell trades in the last month.
Based on Heska Corp’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $39.54 million and quarterly net profit of $3.45 million. In comparison, last year the company earned revenue of $29.76 million and had a net profit of $2.03 million. The company has a one year high of $99.98 and a one year low of $26.26. HSKA’s market cap is $676.9M and the company has a P/E ratio of 69.47.
In the last 30 days, insiders have sold $2.57M worth of HSKA shares and purchased $117K worth of HSKA shares. The insider sentiment on Heska Corp has been negative according to 49 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Nancy Wisnewski’s trades have generated a 32.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Heska Corp. engages in the research, development and manufacture of veterinary products. It operates through the two segments: Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.